ADDF Statement on Biogen and Eisai Discontinuing Trials of Aducanumab
Read More
ADDF CSO Dr. Howard Fillit featured in Life Science Leader
Read It
The BEACON Study Explores Treating Alzheimer's by Targeting Inflammation
Learn More
AFTD Joins Us & Bill Gates to Expand Initiative's Focus on FTD Biomarkers
ADDF Review in Neurology® on Aging Biology & Novel Alzheimer's Targets
Accelerate the Discovery of Drugs to Prevent and Treat Alzheimer's
About Us
CognitiveVitality.org:empowering you to protect your aging brain
Connecting researchers with CROs and drug discovery expertise
Mar 21
Biogen and Eisai Discontinue Trials of Aducanumab
Mar 4
Marcia Gay Harden Honored at Hope on the Horizon Event
Apr 9
Second Annual Memories Matter
Apr 12
Program to Accelerate Clinical Trials
Neuroimaging and CSF Biomarker Development
Prevention Beyond the Pipeline
Drug Discovery
